Markets · 1 sources covering this

Dollar-Denominated EM Assets Outperforming: UBS' Khan

Shamaila Khan, UBS Asset Management Head of Global EM and APAC Fixed Income, speaks with Bloomberg TV about the strong opportunities in dollar-denominated emerging market assets. (Source: Bloomberg)

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·1h ago
Dollar-Denominated EM Assets Outperforming: UBS' Khan
Shamaila Khan, UBS Asset Management Head of Global EM and APAC Fixed Income, speaks with Bloomberg TV about the strong opportunities in dollar-denominated emerging market assets. (Source: Bloomberg)
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/888cdfcfced8c7fae2f5ae6bfbff51bb90c12d1d"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Dollar-Denominated EM Assets Outperforming: UBS' Khan"></iframe>

Dollar-Denominated EM Assets Outperforming: UBS' Khan

How 1 sources are covering this

Dollar-Denominated EM Assets Outperforming: UBS' Khan

More from Markets

Industrial Metals Decline as Gulf Strikes Dampen Deal Optimism

Oasis Says Japan Proposal on Shareholders Hurts Retail Investors

Cancer treatment already costs hundreds of thousands of dollars — and it’s about to get even worse

Chinese Coal Disaster to Ripple Through Steel, Power, Chemicals

Reader

Trust & legal

Across the network

How 1 sources are covering this

Dollar-Denominated EM Assets Outperforming: UBS' Khan

More from Markets

Industrial Metals Decline as Gulf Strikes Dampen Deal Optimism

Oasis Says Japan Proposal on Shareholders Hurts Retail Investors

Cancer treatment already costs hundreds of thousands of dollars &#x2014; and it&#x2019;s about to get even worse

Chinese Coal Disaster to Ripple Through Steel, Power, Chemicals

Reader

Trust & legal

Across the network

Cancer treatment already costs hundreds of thousands of dollars — and it’s about to get even worse